RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsJanuary 17, 2023 - "We continue to expect that deals in the $5 billion to $15 billion range will be the market sweet spot but see the potential for one or more deals in the $20 billion to $40 billion range before year-end,” the report says. “In transactions, pharmaceutical and life sciences companies may also need to strike the right combination of acquiring in-line/Phase III products to meet near-term portfolio needs with longer-term (Phase I and II) value creating pipeline assets.
https://endpts.com/pwc-predicts-flurry-of-5b-to-15b-biotech-deals-in-2023/